READ OUR LATEST BLOG POSTS
-
Immunotherapy Gene Editing Breakthrough Electrifies the Scientific Community
07/18/2018 - Mesothelioma ResearchREAD MORE »A research team that included scientists from the University of California San Francisco (UCSF) recently announced a major breakthrough in immunotherapy gene editing. UCSF is one of the top medical schools in the country and is an important resource for mesothelioma patients because the UCSF Medical Center’s Thoracic Oncology Program includes specialists in…
-
Lung Cancer Specialist Nurses Increase Patient Survival
07/16/2018 - Mesothelioma TreatmentREAD MORE »When you think about your mesothelioma care team, you probably think about mesothelioma specialists, radiologists, pathologists, and other medical specialists with a background in mesothelioma care and oncology. Even though nurses are an integral member of your mesothelioma care team, they might not even make the list. Nurses are expected to step in…
-
Potential Mesothelioma Metastasis Treatment Goes to Clinical Trial
07/13/2018 - Clinical TrialsREAD MORE »Mesothelioma metastasis occurs when the cancer forms new tumors in other parts of your body. It often means there has been a serious progression of the disease. A new clinical trial, A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies, will study whether a new immunotherapy drug can slow or reverse…
RESEARCH WE'VE FUNDED
-
Kazan Law Funds Research on Pleural Mesothelioma Tumor Staging
05/09/2018 - FoundationAt the 14th Conference of the International Mesothelioma Interest Group (iMig) in Ottawa, Canada, this May, mesothelioma research was presented in a number of plenary sessions and dozens of mini-symposiums. The topics of the sessions ranged from mesothelioma immunotherapy and surgery to imaging and biomarkers. Many advances in the study and diagnosis of…
-
Kazan Law Gold Sponsor for International Mesothelioma Interest Group 2018
04/27/2018 - FoundationStarting on May 2, 2018, a remarkable group of people will gather in Ottawa, Canada: the International Mesothelioma Interest Group. The group is made up of medical researchers, oncologist, doctors, and advocates bound together by their interest in advancing knowledge about mesothelioma tumors and mesothelioma treatment. Steven Kazan, Founding, Senior and Managing Partner…
-
Mesothelioma Immunotherapy Clinical Trials Target Mesothelin Protein
11/27/2017 - Clinical TrialsMesothelioma immunotherapy treatments are producing good results for some mesothelioma patients and offering hope for many more. Research into new and better mesothelioma immunotherapy protocols is ongoing; there are a large number of clinical trials underway, with the promise of new treatments for mesothelioma patients. Several recent studies have focused attention on a…